Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction

Sci Rep. 2016 Sep 2:6:32595. doi: 10.1038/srep32595.

Abstract

To guide the use of human mesenchymal stem cells (MSCs) toward clinical applications, identifying pluripotent-like-markers for selecting MSCs that retain potent self-renewal-ability should be addressed. Here, an insulin-like growth factor 1 receptor (IGF1R)-expressing sub-population in human dental pulp MSCs (hDSCs), displayed multipotent properties. IGF1R expression could be maintained in hDSCs when they were cultured in 2% human cord blood serum (hUCS) in contrast to that in 10% fetal calf serum (FCS). Cytokine array showed that hUCS contained higher amount of several growth factors compared to FCS, including IGF-1 and platelet-derived growth factor (PDGF-BB). These cytokines modulates the signaling events in the hDSCs and potentially enhances engraftment upon transplantation. Specifically, a bidirectional cross-talk between IGF1R/IGF1 and CXCR4/SDF-1α signaling pathways in hDSCs, as revealed by interaction of the two receptors and synergistic activation of both signaling pathways. In rat stroke model, animals receiving IGF1R(+) hDSCs transplantation, interaction between IGF1R and CXCR4 was demonstrated to promote neuroplasticity, therefore improving neurological function through increasing glucose metabolic activity, enhancing angiogenesis and anti-inflammatiory effects. Therefore, PDGF in hUCS-culture system contributed to the maintenance of the expression of IGF1R in hDSCs. Furthermore, implantation of IGF1R(+) hDSCs exerted enhanced neuroplasticity via integrating inputs from both CXCR4 and IGF1R signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / metabolism
  • Apoptosis / drug effects
  • Becaplermin
  • Brain Ischemia / complications
  • Brain Ischemia / physiopathology
  • Cerebrovascular Circulation / drug effects
  • Chemokine CXCL12 / pharmacology
  • Child
  • Child, Preschool
  • Cytokines / metabolism
  • Dental Pulp / cytology
  • Glucose / metabolism
  • Humans
  • Insulin-Like Growth Factor I / pharmacology
  • Male
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism*
  • Neovascularization, Physiologic / drug effects
  • Nerve Regeneration / drug effects
  • Neurogenesis / drug effects
  • Neuronal Plasticity* / drug effects
  • Protein Binding / drug effects
  • Proto-Oncogene Proteins c-sis / pharmacology
  • Rats
  • Receptor, IGF Type 1 / metabolism*
  • Receptors, CXCR4 / metabolism*
  • Recovery of Function / drug effects
  • Stem Cell Transplantation
  • Stroke / complications
  • Stroke / physiopathology
  • Stroke / therapy
  • Umbilical Cord / cytology

Substances

  • Anti-Inflammatory Agents
  • CXCR4 protein, human
  • Chemokine CXCL12
  • Cytokines
  • Proto-Oncogene Proteins c-sis
  • Receptors, CXCR4
  • Becaplermin
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1
  • Glucose